loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2001_364___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    SAFC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Sigma-Aldrich Corporation Saint Louis US (1)

    filter

    01 Hyaluronidase, Type VIII, (Product Number H2032) (1)

    filter

    01 U.S.A (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Sigma-Aldrich Corporation Saint Lou...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Hyaluronidase, Type VIII, (Product Number H2032)

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2001-364 - Rev 01
    Expired
    TSE
    2005-03-18
    2007-04-09
    912
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2001-364 - Rev 01 of Sigma-aldrich Corporation Saint Louis Us

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2001-364 - Rev 01 of Sigma-aldrich Corporation Saint Louis Us 1

    20

    Sigma-aldrich Corporation Saint Louis Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Hyaluronidase, Type VIII, (Product Number H2032), supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2001-364 - Rev 01

    This TSE Type CEP, issued on March 18, 2005, remains in force until April 09, 2007, ensuring its reliability within the pharmaceutical industry.

    Substance Number 912 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY